{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Benzimidazole cannabinoid agonists", "item": "https://www.patentleaderboard.com/patent/8193369"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Benzimidazole cannabinoid agonists

Benzimidazole cannabinoid agonists

US Patent 8193369 · Granted Jun 5, 2012

Estimated economic value: $78,299,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2022
[1,2,4]triazolo[1,5-a]pyrimidine compounds as PDE2 inhibitors2021
[1,2,4]triazolo[1,5-a]pyrimidin-7-yl compound2021
[1,2,4]triazolo[1,5and#8208;A]pyrimidine compounds as PDE2 inhibitors2021
Substituted imidazoles as N-type calcium channel blockers2020
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase m2020
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase m2020
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase m2019
Substituted 3,4-dihydro-2H-pyrido[1,2-a]pyrazine-1,6-diones as gamma secretase m2019
Substituted imidazoles as gamma secretase modulators2018
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inh2018
2,3,4,5-tetrahydropyridin-6-amine and 3,4-dihydro-2H-pyrrol-5-amine compound inh2018